Evidence map›Paper›PMID 21239484›Full record

ArticleThe Journal of biological chemistry2011

Arginine deficiency causes runting in the suckling period by selectively activating the stress kinase GCN2.

Vincent Marion, Selvakumari Sankaranarayanan, Chiel de Theije, Paul van Dijk, Patrick Lindsey, Marinus C Lamers, Heather P Harding, David Ron, Wouter H Lamers, S Eleonore Köhler

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Arginases and arginine deficiency syndromes.Current opinion in clinical nutrition and metabolic care · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Vincent MarionDept of Anatomy & Embryology and NUTRIM School for Nutrition, Toxicology, and Metabolism, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Selvakumari Sankaranarayanan
Chiel de Theije
Paul van Dijk
Patrick Lindsey
Marinus C Lamers
Heather P Harding
David Ron
Wouter H Lamers
S Eleonore Köhler
University of Cambridge · GBAcademic Medical Center · NLMaastricht University · NLMax Planck Institute of Immunobiology and Epigenetics · DE

Funding

Medical Research Council G0600717Wellcome Trust 084812
6 · The paper itself

Abstract

Suckling "F/A2" mice, which overexpress arginase-I in their enterocytes, develop a syndrome (hypoargininemia, reduced hair and muscle growth, impaired B-cell maturation) that resembles IGF1 deficiency. The syndrome may result from an impaired function of the GH-IGF1 axis, activation of the stress-kinase GCN2, and/or blocking of the mTORC1-signaling pathway. Arginine deficiency inhibited GH secretion and decreased liver Igf1 mRNA and plasma IGF1 concentration, but did not change muscle IGF1 concentration. GH supplementation induced Igf1 mRNA synthesis, but did not restore growth, ruling out direct involvement of the GH-IGF1 axis. In C2C12 muscle cells, arginine withdrawal activated GCN2 signaling, without impacting mTORC1 signaling. In F/A2 mice, the reduction of plasma and tissue arginine concentrations to ∼25% of wild-type values activated GCN2 signaling, but mTORC1-mediated signaling remained unaffected. Gcn2-deficient F/A2 mice suffered from hypoglycemia and died shortly after birth. Because common targets of all stress kinases (eIF2α phosphorylation, Chop mRNA expression) were not increased in these mice, the effects of arginine deficiency were solely mediated by GCN2.

Indexed as

Signal TransductionAmino Acid Metabolism, Inborn ErrorsAnimalsAnimals, SucklingArginaseArginineB-LymphocytesGrowth HormoneHair DiseasesHypoglycemiaInsulin-Like Growth Factor IMechanistic Target of Rapamycin Complex 1MiceMice, KnockoutMultiprotein ComplexesMuscular DiseasesArg1 protein, mouseArginaseArginineEif2ak4 protein, mouseGrowth Hormoneinsulin-like growth factor-1, mouseInsulin-Like Growth Factor IMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesProteinsProtein Serine-Threonine KinasesTOR Serine-Threonine Kinases

Identifiers

PMID21239484
PMCPMC3058991
OpenAlexW2130478809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.